Possible scenario
Skeptical Validation Cycle
20% Chance
Following Epoch AI's recent finding that agents still fail at research automation, reviewers treat Sakana's claims cautiously. The product may still be useful, but replication bottlenecks, benchmark design issues, and human oversight requirements limit the near-term disruption narrative.
Secondary impacts
- Technology -0.7%
- Business Services -0.2%
Tickers
- NVDA-0.4%
- META-0.3%
- GOOG-0.1%
Portfolio impact
S&P 500-0.3%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.